Yamanaka T

No ORCID on file · 3 papers in corpus
case-report 2025
Surgical case reports ·doi:10.70352/scrj.cr.25-0227

INTRODUCTION: Tamoxifen (TAM) is a well-established treatment for hormone receptor-positive breast cancer with a known side-effect profile that includes hot flashes, genital bleeding, and diarrhea (0.1%-5%). Other notable side effects inclu…

diagnostic-accuracy 2021
International journal of clinical oncology ·doi:10.1007/s10147-021-01914-y

BACKGROUND: Tissue factor pathway inhibitor 2 (TFPI2) is a novel serum biomarker that discriminates ovarian clear cell carcinoma (CCC) from borderline ovarian tumors (BOTs) and non-clear cell epithelial ovarian cancers (EOCs). Here, we exam…

case-report 2018
Surgical case reports ·doi:10.1186/s40792-018-0500-x

BACKGROUND: Clear cell carcinoma commonly occurs in the ovary and kidney, and clear cell cholangiocarcinoma was rarely reported. Differential diagnosis which the origin of the tumor located on the liver surface is intrahepatic or extrahepat…